In myelofibrosis, combinations of rufolitinib reduce spleen volume.

Published Date: 15 Dec 2023

More patients experienced reductions when pelabresib or navitoclax were combined.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

It Is Cancer in Kate Middleton.

2.

Treatment of Oligometastatic EGFR-Mutant Lung Cancer

3.

Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients

4.

In myelofibrosis, combinations of rufolitinib reduce spleen volume.

5.

Researchers find distinct cell receptors with the potential for new treatments.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot